News
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the matter told CNN.
Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...
MedPage Today on MSN3d
Bill Treats mRNA Vaccines as 'Weapons'; Brain Drain Begins? New Ice Bucket ChallengeA bill introduced by Republicans in the Minnesota state legislature calls mRNA vaccines "weapons of mass destruction" and if ...
Vaccine Nation is a warning about the acceleration of the anti-vaccination movement during the pandemic and worrying declines ...
A bull market will eventually follow the challenging and volatile times we face, and, based on history, this bull run is ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from COVID-19 to personalized cancer therapies.
The COVID vaccine brought a renewed public debate around vaccines. A new film airing on PBS explores the politicization of ...
Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, ...
The cabinet's decision to pause vaccine purchases followed a recommendation by vaccine opponent Peter Kotlar, the ...
In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...
Peter Kotlár has long promoted fringe theories about mRNA vaccines, claiming they "cause the human body to produce toxins." ...
The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback